☆ 4.5 Article

A randomized, double-blinded, placebo-controlled, dose-ranging study measuring the effect of an adenosine agonist on infarct size reduction in patients undergoing primary percutaneous,transluminal under coronary angioplasty: The ADMIRE (AmP579 Delivery for Myocardial Infarction REduction) study

AMERICAN HEART JOURNAL (2003)

Rate this paper

The primary rating indicates the level of overall quality for the paper. Secondary ratings independently reflect strengths or weaknesses of the paper.

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

A randomized, double-blinded, placebo-controlled, dose-ranging study measuring the effect of an adenosine agonist on infarct size reduction in patients undergoing primary percutaneous,transluminal under coronary angioplasty: The ADMIRE (AmP579 Delivery for Myocardial Infarction REduction) study

Rate this paper

Publish scientific posters with Peeref

Find the ideal target journal for your manuscript

Export Citation

Share Paper